Structural changes in the pharmaceutical manufacturing industry are set to create significant opportunities for logistics service providers in the next few years.
In a highly competitive market, pharmaceutical drug manufacturers are faced with several industry issues including the expiry of blockbuster drug patents, increasing government legislation and a lack of new drugs in the development pipeline. This has resulted in many mergers/acquisitions in the industry which in turn has meant that supply chains are becoming ever more complex.
In addition manufacturing is becoming more globalised, with supply chains extending to remote production locations.
What will you learn from Global Pharmaceutical Logistics 2012?
Global Pharmaceutical Logistics 2012 will provide you with answers to the following questions and many more:
- What are the major trends affecting the global pharmaceutical drugs industry and what is their impact on the logistics sector?
- How are supply chains organized and what roles do the manufacturers, distributors, logistics companies and the major drug purchasers play?
- What are the supply chain and production strategies of the major manufacturers and distributors within the sector?
- What are the regional variations within the pharma sector and how does legislation impact on supply chains?
- How big is the pharma logistics market size and what are its prospects for growth?
- Which region will grow the fastest?
- What are the greatest pharma supply chain challenges?
- What services have logistics and express companies developed to meet the out- sourcing needs of drug companies?
Market trends, developments, size and forecasts
Global Pharmaceutical Logistics 2012 will give you an all-round understanding of the global pharmaceutical sector. It provides an in-depth analysis of the trends impacting the drugs markets, such as how the decline of the 'blockbuster' drugs and the rise of 'generics' will impact on supply chains.
It examines how logistics companies are developing new services to meet the increasingly sophisticated and intricate needs of the manufacturers as well as how legislative changes in emerging markets have created new opportunities.
The report includes logistics market sizing estimates by region as well as five year forecasts, allowing you to identify which regions have the best growth prospects.
It examines the significant trends which are affecting investment in the industry and the performance of the companies which have developed the most successful operations.
Profiles of the leading pharma logistics providers DHL, FedEx and UPS are amongst the most innovative solutions providers to the industry. However, many other logistics providers offer specialised services, whether they are in one geographic region or service. Perhaps a similar theme among many providers is the fact that they are expanding their service offerings to emerging markets.
Global Pharmaceutical Logistics 2012 provides an overview of the solutions provided by the leading companies present in the market – including looking at the technologies they have developed to meet.
Table of Contents
Table of Figures
1.0 Executive Summary
3.0 Global Pharmaceutical Drug Market
3.1.2 Distributor/Wholesale Market
4.0 Major Providers
4.1.1 Pharmaceutical Manufacturers
220.127.116.11 Novartis International AG
4.1.2 Generic Pharmaceutical Manufacturers
18.104.22.168 Teva Pharmaceutical
22.214.171.124 Watson Pharmaceutical
4.1.3 Pharmaceutical Wholesale Distributors
126.96.36.199 Cardinal Health
188.8.131.52 Medipal Holdings Corporation
184.108.40.206 Sinopharm Group
5.3 North America
5.3.3 United States
220.127.116.11 Puerto Rico
5.4 South America
6.0 The global pharmaceutical logistics market
7.0 Pharmaceutical Logistics Market Size
8.0 Pain points in the pharmaceutical supply chain
8.1 Information Technology
8.2 Legislation and Regulations
18.104.22.168 European Union
22.214.171.124 North America
8.3 Intellectual Property and Security
9.0 Logistics and Transportation Service Offerings
9.1.1 Cold Chain
9.1.2 Air freight
126.96.36.199 DHL Global Forwarding
188.8.131.52 DHL Express
9.1.3 Distribution Services
184.108.40.206 DHL Supply Chain
9.1.4 Reverse Logistics
9.1.5 Logistics Providers
220.127.116.11 DB Schenker
18.104.22.168 DHL Supply Chain
22.214.171.124 DHL Express
126.96.36.199 DHL Global Freight Forwarding
188.8.131.52 Exel (USA)
184.108.40.206 Expeditors International
220.127.116.11 Fiege Logistics
18.104.22.168 Hellmann Worldwide Logistics
22.214.171.124 Kerry Logistics
126.96.36.199 Kuehne + Nagel
188.8.131.52 TNT Express
184.108.40.206 UTi Worldwide
Contact Transport Intelligence
Table of Figures
Global Pharmaceutical Sales by Region (%)
Pharmaceutical sales growth by region
Pharmaceutical Sales Growth for Emerging Markets
Revenues of Top Pharmaceutical Companies [US$bn]
Pfizer: 2010 Revenue % by Geographic Region
Novartis: 2010 Revenue % by Geographic Region
Sanofi-Aventis: 2010 Financials % by Geographic Region
Merck: 2010 Financials % by Geographic Region
Roche: 2010 Financials % by Geographic Region
Revenues of Major Generic Companies [US$bn]
Major Pharmaceutical Industry Parks
India's Bulk Drug and Formulation Facilities - Total manufacturing sites
Top 5 Pharmaceutical Trading Partners: 2010 Exports
European Union's Top 5 Pharmaceutical Trading Partners: 2010 Imports
Typical Pharmaceutical Manufacturing Supply Chain: Blockbuster Drug Model
Vertical Sector: Pharmaceutical - Total Logistics Market Size [€m]
Vertical Sector: Pharmaceutical - Total Logistics Market Forecast 2015 [€m]
Vertical Sector: Pharmaceutical - Total Logistics Market Size by Geographic Location [ m]
Global Cold Chain Market [US$ bn]
Healthcare Shared Network
FedEx Temperature Controlled Storage Locations
FedEx Dry Ice De-icing Capabilities
K+N North American Network of Multi-client Distribution Centres
Panalpina's Temperature Visibility System
TNT Express: Clinical Express
- Novartis International AG
- Teva Pharmaceutical
- Watson Pharmaceutical
- Cardinal Health
- Medipal Holdings Corporation
- Sinopharm Group